Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Head & Neck 5Breast 4Genitourinary 3Thoracic 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Hematologic Neoplasms 1Body Weight 1

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 26Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Interviews as Topic 10Vincristine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dietary Supplements × Other hematologic neoplasm × Clear all
NCT05460013 2026-05-11

Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation

RenJi Hospital

Phase NA Completed
100 enrolled 21 charts
Other hematologic neoplasm

Body Weight, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡